• BEAVO, J.A. & HOUSLAY, M.D. (1990). Isoenzymes of Cyclic Nucleotide Phosphodiesterases. Chichester: John Wiliey & Sons.
  • BRYSON, S.E. & ROGER, I.W. (1987). Effects of phosphodiesterase inhibitors on normal and chemically skinned isolated smooth muscle. Br. J. Pharmacol., 92, 673681.
  • CORTIJO, J., SARRIA, B., PEDROS, C., PERPIÑA, M., PARIS, F. & MORCILLO, E. (1992). The relaxant effects of cromakalim (BRL 34915) on human isolated airway smooth muscle. Naunyn-Schmiedebergs Arch. Pharmacol., 346, 462468.
  • GIEMBYCZ, M.A. & DENT, G. (1992). Prospects for selective nucleotide phosphodiesterase inhibitors in the treatment of bronchial asthma. Clin. Exp. Allergy, 22, 337344.
  • GRISTWOOD, R.W., BELETA, J., BOU, J., CARDELUS, I., FERNANDEZ, A.G., LLENAS, J. & BERGA, P. (1992). Studies on the cardiac actions of flosequinan in vitro Br. J. Pharmacol., 105, 985991.
  • GRISTWOOD, R.W., EDEN, R.J., OWEN, D.A.A. & TAYLOR, E.M. (1986). Pharmacological studies with SK&F 94120 a novel positive inotropic agent with vasodilator activity. J. Pharm. Pharmacol., 381, 452459.
  • GRISTWOOD, R.W., LLUPIA, J., FERNANDEZ, A.G. & BERGA, P. (1991). Effects of theophylline compared with prednisolone on late phase airway leukocyte infiltration in guinea-pigs. Int. Arch. Allergy Appl. Immunol., 94, 293294.
  • GRISTWOOD, R.W. & SAMPFORD, K.A. (1987). Inhibition of histamine induced bronchoconstriction by SK&F 94836, salbutamol and theophylline in the anaesthetised guinea-pig. Br. J. Pharmacol., 92, 631P.
  • HALL, I.P., TOWNSEND, P., DAYKIN, K. & WIDDOP, S. (1992). Control of tissue cyclic AMP content in primary cultures of human airway smooth muscle cells. Br. J. Pharmacol., 105, 71P.
  • LIVI, G.P., KMETZ, P., MEGAN, M., McHALE, M.M., CIESLINSKI, L.B., SATHE, G.M., TAYLOR, D.P., DAVIS, R.L., TORPHY, T.J. & BALCAREK, J.M. (1990). Cloning and expression of cDNA for a human low-Km, rolipram-sensitive cyclic AMP phosphodiesterase. Mol. Cell. Biol., 10, 6: 26782686.
  • NICHOLSON, C.D., CHALLIS, R.A.J. & SHAHID, M. (1991). Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes. Trends Pharmacol. Sci., 12, 1927.
  • NICHOLSON, C.D., JACKMAN, S.A. & WILKE, R. (1989). The ability of denbufylline to inhibit cyclic nucleotide phosphodiesterase and its affinity for adenosine receptors and the adenosine re-uptake site. Br. J. Pharmacol., 97, 889897.
  • NOLTE, D. (1971). Lungenfunktionsuntersuchungen zur bronchospas-molytischen Wirkung von 3,7-Dimethyl-l(5-oxo-hexyl)-xanthin. Arzneimittel-Forschung., 21, 14531456.
  • PERSSON, C.G.A. (1986). Overview of effects of theophylline. J. Allergy Clin. Immunol., 78, 780787.
  • REEVES, M.L., LEIGH, B.K. & ENGLAND, P.J. (1987). The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle. Biochem. J., 241, 535541.
  • SHAHID, M., PHILPOT, A.J., De BOER, J., ZAAGSMA, J. & NICHOLSON, C.D. (1992). Cyclic nucleotide phosphodiesterase (PDE) isoenzyme activities in human peripheral bronchi. Br. J. Pharmacol., 105, 129P.
  • SILVER, P.J., HAMEL, L.T., PERRONE, M.H., BENTLEY, R.G., BUSHOVER, C.R. & EVANS, D.B. (1988). Differential pharmacologic sensitivity of cyclic nucleotide phosphodiesterase isoenzymes isolated from cardiac muscle, arterial and airway smooth muscle. Eur. J. Pharmacol., 150, 8594.
  • SVEDMYR, N. (1988). Asthma: Basic Mechanisms and Clinical Management. ed. Barnes, P.J., Rogers, I.W. & Thompson, N.C. pp. 607625.London: Academic Press.
  • TAKAGI, K., OGAWA, K., TANAKA, H., SATAKE, T., WATANABE, Y., CHIJIWA, T. & HIDAKA, H. (1992). Relaxant effects of various xanthine derivatives. Relationship to cyclic nucleotide phosphodiesterase inhibition. Adv. Second Messenger Phosphorylation Res., 25, 353362.
  • THOMPSON, W.J. & STRADA, S.J. (1984). Cyclic nucleotide phosphodiesterase (PDE). In Methods of Enzymatic Analysis. ed. Bergmayer, H.U. Vol. IV, pp. 127134. Weinheim Verlag Chemie.
  • TORPHY, T.J. & UNDEM, B.J. (1991). Phosphodiesterase inhibitors: new opportunities for the treatment of asthma. Thorax, 416, 512523.
  • WARD, A. & CLISSOLD, S.P. (1987). Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs, 34, 5097.